Skip to main content

Parallel Advisors, LLC

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1690010 SAN FRANCISCO, CA

Position in ESPR

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$0
+$0 QoQ
Shares Held
259
-99.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $5,825,413 across 37 Drug Manufacturers - Specialty & Generic names. ESPR ranks #37 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 259
2026-03-31 96,254
2025-12-31 106,684
2025-09-30 117,424
2025-06-30 127,424
2025-03-31 10,000
2024-12-31 10,000
2024-09-30 244,000
2024-06-30 239,000
2024-03-31 239,000
2023-12-31 478,000
2023-09-30 478,000
2023-03-31 169
2022-09-30 53
2022-06-30 35
2021-12-31 1,526
2021-09-30 126
2021-06-30 2
2021-03-31 2
2020-12-31 5
2020-09-30 10
2020-03-31 17,710